Overview

Safety and Pharmacokinetics of Probucol and Cilostazol

Status:
Completed
Trial end date:
2008-08-01
Target enrollment:
Participant gender:
Summary
to investigate the safety and pharmacokinetics, in healthy adult male subjects
Phase:
Phase 4
Details
Lead Sponsor:
Korea Otsuka Pharmaceutical Co., Ltd.
Collaborator:
Otsuka Pharmaceutical Co., Ltd.
Treatments:
Cilostazol
Probucol